Kiora Pharmaceuticals (NASDAQ: KPRX) reported Q2 EPS of ($0.34), $0.17 better than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Kiora Pharmaceuticals (KPRX) click here.